Upgrade to SI Premium - Free Trial

Stifel Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold

August 19, 2020 9:26 AM
Stifel analyst Paul Matteis downgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from Buy to Hold with a price target of $100.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Downgrades Hot Comments Hot Downgrades

Next Articles